RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000129.xml
Kardiologie up2date 2022; 18(04): 314-319
DOI: 10.1055/a-1949-5464
DOI: 10.1055/a-1949-5464
SOP
SOP Vakzininduzierte immunogene thrombotische Thrombozytopenie
In dieser Rubrik stellen wir Standard Operating Procedures (SOPs) für perioperativ und intensivmedizinisch relevante Prozesse vor. Die Form ist eher im Sinne einer Schablone zu verstehen als – durchaus subjektiv gefärbte – Anregung, eigene, auf lokale Gegebenheiten adaptierte stationsinterne SOPs zu entwerfen und zu implementieren.
Publikationsverlauf
Artikel online veröffentlicht:
06. Dezember 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Greinacher A, Thiele T, Warkentin TE. et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med 2021; 384: 2092-2101 DOI: 10.1056/NEJMoa2104840. (PMID: 33835769)
- 2 Pavord S, Scully M, Hunt BJ. et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med 2021; 385: 1680-1689 DOI: 10.1056/NEJMoa2109908. (PMID: 34379914)
- 3 Perry RJ, Tamborska A, Singh B. et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet 2021; 398: 1147-1156 DOI: 10.1016/S0140-6736(21)01608-1. (PMID: 34370972)
- 4 Schultz NH, Sorvoll IH, Michelsen AE. et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384: 2124-2130 DOI: 10.1056/NEJMoa2104882. (PMID: 33835768)
- 5 Scully M, Singh D, Lown R. et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med 2021; 384: 2202-2211 DOI: 10.1056/NEJMoa2105385. (PMID: 33861525)
- 6 Tiede A, Sachs UJ, Czwalinna A. et al. Prothrombotic immune thrombocytopenia after COVID-19 vaccine. Blood 2021; 138: 350-353 DOI: 10.1182/blood.2021011958. (PMID: 34323939)
- 7 Muir KL, Kallam A, Koepsell SA. et al. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. N Engl J Med 2021; 384: 1964-1965 DOI: 10.1056/NEJMc2105869. (PMID: 33852795)
- 8 Huynh A, Kelton JG, Arnold DM. et al. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature 2021; 596: 565-569 DOI: 10.1038/s41586-021-03744-4. (PMID: 34233346)
- 9 Greinacher A. Heparin-Induced Thrombocytopenia. N Engl J Med 2015; 373: 1883-1884 DOI: 10.1111/jth.15344. (PMID: 33872452)
- 10 Salih F, Schonborn L, Kohler S. et al. Vaccine-Induced Thrombocytopenia with Severe Headache. N Engl J Med 2021; 385: 2103-2105 DOI: 10.1056/NEJMc2112974. (PMID: 34525282)
- 11 Greinacher A, Langer F, Makris M. et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources. J Thromb Haemost 2022; 20: 149-156 DOI: 10.1111/jth.15572. (PMID: 34693641)
- 12 Vayne C, Rollin J, Gruel Y. et al. PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 376-378 DOI: 10.1056/NEJMc2106383. (PMID: 34010527)
- 13 Platton S, Bartlett A, MacCallum P. et al. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination. J Thromb Haemost 2021; 19: 2007-2013 DOI: 10.1111/jth.15362. (PMID: 33973336)
- 14 Sachs UJ, Cooper N, Czwalinna A. et al. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison. Thromb Haemost 2021; 121: 1622-1627 DOI: 10.1055/a-1535-9002. (PMID: 34169493)
- 15 Thiele T, Weisser K, Schonborn L. et al. Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. Lancet Reg Health Eur 2022; 12: 100270 DOI: 10.1016/j.lanepe.2021.100270. (PMID: 34901912)
- 16 Graf T, Thiele T, Klingebiel R. et al. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J Neurol 2021; 268: 4483-4485 DOI: 10.1007/s00415-021-10599-2. (PMID: 34023956)
- 17 Oldenburg J, Klamroth R, Langer F. et al. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. Hamostaseologie 2021; 41: 184-189 DOI: 10.1055/a-1469-7481. (PMID: 33822348)
- 18 Bourguignon A, Arnold DM, Warkentin TE. et al. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 720-728 DOI: 10.1056/NEJMoa2107051. (PMID: 34107198)
- 19 Gunther A, Bramer D, Pletz MW. et al. Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report. Vaccines (Basel) 2021; 9: 1344 DOI: 10.3390/vaccines9111344. (PMID: 34835275)
- 20 Gessler F, Schmitz AK, Dubinski D. et al. Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT. J Clin Med 2021; 10: 2777 DOI: 10.3390/jcm10132777. (PMID: 34202817)
- 21 Bundesärztekammer. Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten – Gesamtnovelle 2020. Zugriff am 05. Januar 2022 unter: https://www.bundesaerztekammer.de/aerzte/medizin-ethik/wissenschaftlicher-beirat/veroeffentlichungen/haemotherapietransfusionsmedizin/querschnitt-leitlinie/
- 22 Patriquin CJ, Laroche V, Selby R. et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med 2021; 385: 857-859 DOI: 10.1056/NEJMc2109465. (PMID: 34233107)
- 23 Schonborn L, Thiele T, Kaderali L. et al. Decline in Pathogenic Antibodies over Time in VITT. N Engl J Med 2021; 385: 1815-1816 DOI: 10.1056/NEJMc2112760. (PMID: 34496199)